CGNX Price Prediction Next Week
Based on the provided data and technical analysis, here's the price prediction for CGNX for the next trading week:
Technical Analysis
- RSI (14) at 28.26 indicates oversold conditions
- MACD shows bearish momentum with -0.58 and negative histogram
- Stock is trading below all major moving averages (5,10,20,60,200-day)
- Bollinger Bands show price at lower band (33.14), suggesting potential bounce
News Sentiment Analysis
- Stock recently entered oversold territory with RSI reading of 28.5
- Multiple analysts maintain Hold ratings, with KeyBanc and Truist Financial reiterating Hold positions
- Insider sentiment is negative with recent CTO selling of shares
- Q4 results showed mixed performance with revenue challenges but earnings beat
Price Targets for Next Week
- Support Levels: $32.07 (Fibonacci S2), $33.14 (Lower BB)
- Resistance Levels: $36.76 (Fibonacci Pivot), $38.92 (20-day SMA)
Prediction Based on technical indicators and news sentiment:
- Base case (60% probability): Range-bound trading between $33.20-$35.50
- Bullish case (25% probability): Bounce to $36.76 if oversold conditions trigger buying
- Bearish case (15% probability): Drop to $32.07 if market weakness continues
Trading Recommendation HOLD at current levels. While oversold conditions suggest a potential bounce, negative insider sentiment and bearish momentum warrant caution. Better entry points may emerge below $32.50.
CGNX Similar Chart Price Prediction
The price of CGNX is predicted to go up -2.03%, based on the high correlation periods with FICO. The similarity of these two price pattern on the periods is 97.08%.
CGNX
FICO
Down: -2.03%Similarity: 97.08%
CGNX Revenue Forecast
CGNX EPS Forecast
CGNX FAQs
What is bull’s view on CGNX?
What is bear's view on CGNX?
What is CGNX revenue forecast for next quarter？
CGNX Analyst's Forecast
Jamie Cook
Truist Securities
Hold
2025-02-14
Price Target
$43 → $37
Upside
+12.12%
Truist lowered the firm's price target on Cognex to $37 from $43 and keeps a Hold rating on the shares. The company's Q4 results topped EPS estimates by 25% on better sales and profit, but its Q1 guide and what's implied for FY25 suggest that consensus estimates were too high, the analyst tells investors in a research note.
Jamie Cook
Truist Securities
Hold
2025-01-16
Price Target
$42 → $43
Upside
+9.25%
Piyush Avasthy
Citigroup
Hold
2025-01-13
Price Target
$44 → $42
Upside
+12.93%
